These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32057307)

  • 1. Using mouse models to understand Alzheimer's disease mechanisms in the context of trisomy of chromosome 21.
    Cannavo C; Tosh J; Fisher EMC; Wiseman FK
    Prog Brain Res; 2020; 251():181-208. PubMed ID: 32057307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.
    Doran E; Keator D; Head E; Phelan MJ; Kim R; Totoiu M; Barrio JR; Small GW; Potkin SG; Lott IT
    J Alzheimers Dis; 2017; 56(2):459-470. PubMed ID: 27983553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.
    Strupp BJ; Powers BE; Velazquez R; Ash JA; Kelley CM; Alldred MJ; Strawderman M; Caudill MA; Mufson EJ; Ginsberg SD
    Curr Alzheimer Res; 2016; 13(1):97-106. PubMed ID: 26391046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down syndrome, Alzheimer's disease and the trisomy 16 mouse.
    Coyle JT; Oster-Granite ML; Reeves RH; Gearhart JD
    Trends Neurosci; 1988 Sep; 11(9):390-4. PubMed ID: 2469204
    [No Abstract]   [Full Text] [Related]  

  • 5. Alzheimer's Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials.
    Rafii MS
    CNS Drugs; 2020 Aug; 34(8):785-794. PubMed ID: 32506291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease.
    Colacurcio DJ; Pensalfini A; Jiang Y; Nixon RA
    Free Radic Biol Med; 2018 Jan; 114():40-51. PubMed ID: 28988799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome.
    Cárdenas AM; Ardiles AO; Barraza N; Baéz-Matus X; Caviedes P
    Arch Med Res; 2012 Nov; 43(8):645-54. PubMed ID: 23142525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis.
    Wilcock DM; Griffin WS
    J Neuroinflammation; 2013 Jul; 10():84. PubMed ID: 23866266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome.
    Rueda N; Flórez J; Dierssen M; Martínez-Cué C
    Prog Brain Res; 2020; 251():245-268. PubMed ID: 32057309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD).
    Alldred MJ; Lee SH; Petkova E; Ginsberg SD
    Brain Struct Funct; 2015 Sep; 220(5):2983-96. PubMed ID: 25031177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down syndrome and Alzheimer's disease: Common pathways, common goals.
    Hartley D; Blumenthal T; Carrillo M; DiPaolo G; Esralew L; Gardiner K; Granholm AC; Iqbal K; Krams M; Lemere C; Lott I; Mobley W; Ness S; Nixon R; Potter H; Reeves R; Sabbagh M; Silverman W; Tycko B; Whitten M; Wisniewski T
    Alzheimers Dement; 2015 Jun; 11(6):700-9. PubMed ID: 25510383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
    Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
    Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.
    Cataldo AM; Petanceska S; Peterhoff CM; Terio NB; Epstein CJ; Villar A; Carlson EJ; Staufenbiel M; Nixon RA
    J Neurosci; 2003 Jul; 23(17):6788-92. PubMed ID: 12890772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights from mouse models to understand neurodegeneration in Down syndrome.
    Fillat C; Dierssen M; de Lagrán MM; Altafaj X
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):429-38. PubMed ID: 20522013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome.
    Caraci F; Iulita MF; Pentz R; Flores Aguilar L; Orciani C; Barone C; Romano C; Drago F; Cuello AC
    Eur J Pharmacol; 2017 Dec; 817():7-19. PubMed ID: 28987272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer's Disease.
    Alldred MJ; Penikalapati SC; Lee SH; Heguy A; Roussos P; Ginsberg SD
    Mol Neurobiol; 2021 Oct; 58(10):5141-5162. PubMed ID: 34263425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.
    Hamlett ED; Boger HA; Ledreux A; Kelley CM; Mufson EJ; Falangola MF; Guilfoyle DN; Nixon RA; Patterson D; Duval N; Granholm AC
    Curr Alzheimer Res; 2016; 13(1):35-52. PubMed ID: 26391050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's disease.
    Shim KS; Ferrando-Miguel R; Lubec G
    J Neural Transm Suppl; 2003; (67):39-49. PubMed ID: 15068237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome.
    Granholm AC; Sanders L; Seo H; Lin L; Ford K; Isacson O
    Hippocampus; 2003; 13(8):905-14. PubMed ID: 14750653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic linkage in the mouse of genes involved in Down syndrome and Alzheimer's disease in man.
    Reeves RH; Robakis NK; Oster-Granite ML; Wisniewski HM; Coyle JT; Gearhart JD
    Brain Res; 1987 Sep; 388(3):215-21. PubMed ID: 2960420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.